✦ LIBER ✦

Prostate-specific antigen

✍ Scribed by Michael K. Brawer

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 50 KB
Volume: 18
Category: Article
ISSN: 8756-0437
DOI: 10.1002/(sici)1098-2388(200001/02)18:1<3::aid-ssu2>3.0.co;2-i

No coin nor oath required. For personal study only.

✦ Synopsis

Prostate-specific antigen (PSA) has revolutionized the diagnosis and management of men with prostate cancer. Significant advances have been made since the early development of immunoassays. While PSA is useful for staging and monitoring of established disease, it has shown the greatest utility in the realm of early detection realm. PSA is the most important tumor marker; its importance in evaluating men for the possibility of prostate cancer is irrefutable. Enhancing specificity is a pressing need. In this regard, the recognition of the molecular forms of free PSA and complex PSA have shown the most promise and undoubtedly will result in fewer false-positive PSA test results. The salient literature is reviewed and commentary made on the current status of PSA with particular emphasis on methods to enhance its specificity in early detection and applications.

📜 SIMILAR VOLUMES

Comparison of serum prostate specific me

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients

✍ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Prostate-specific antigen in screening o

Prostate-specific antigen in screening of prostate cancer

✍ Dr. T. Ming Chu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

The identification of prostate-specific

The identification of prostate-specific antigen

✍ Richard J. Ablin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Prostate specific antigen complexed to α

Prostate specific antigen complexed to α-1-antichymotrypsin in patients with intermediate prostate specific antigen levels

✍ Takashi Saika; Tomoyasu Tsushima; Yasutomo Nasu; Nobuyuki Kusaka; Yoshiyuki Miya 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

The use of prostate specific antigen den

The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma

✍ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru